US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pliant Therapeutics, Inc.

1.21

+0.07506.64%

Volume:474.47K

Turnover:569.37K

Market Cap:74.05M

PE:-0.42

High:1.23

Open:1.13

Low:1.13

Close:1.13

52wk High:3.46

52wk Low:1.09

Shares:61.45M

Float Shares:55.57M

Volume Ratio:3.85

T/O Rate:0.85%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8668

EPS(LYR):-3.4739

ROE:-64.27%

ROA:-32.87%

PB:0.37

PE(LYR):-0.35

Loading ...

Overview Company News Filings

Tarsus Pharmaceuticals Names Former Allergan CEO David Pyott to Board

Pliant Therapeutics Unveils Data on Oral Integrin Inhibitor for ICI-Resistant Tumors

Pliant Therapeutics Files Initial Beneficial Ownership Statement for Chief Operating Officer Minnie Kuo

Pliant Therapeutics Appoints Minnie Kuo as Chief Operating Officer

Pliant Therapeutics Inc - Terminates Cmo ÉRic Lefebvre Effective December 15 - SEC Filing

THOMSON REUTERS

Pliant Therapeutics Announces Departure of Chief Medical Officer Éric Lefebvre

Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors

Benzinga_recent_news

BRIEF-Pliant Therapeutics Announces Interim Data From PLN-101095

Pliant Therapeutics Announces Interim Data From Pln-101095 in Patients With Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

THOMSON REUTERS

Pliant Therapeutics Inc: to Accelerate Development of Pln-101095 With Initiation of a Phase 1B Expansion Trial in 2026

THOMSON REUTERS

Pliant Therapeutics Reports Promising Interim Results for PLN-101095 in Refractory Solid Tumors

Pliant Therapeutics Q3 Net Income USD -26.301 Million

Canaccord Genuity Keeps Their Hold Rating on Pliant Therapeutics (PLRX)

RBC Capital Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)

Pliant Therapeutics Q3 net loss narrows to $26.3 mln

Pliant Therapeutics reports third quarter net loss of $26.3 million

Pliant Therapeutics Inc expected to post a loss of 52 cents a share - Earnings Preview

Pliant Therapeutics Announces CBO Hans Hull’s Resignation

Pliant Therapeutics Chief Business Officer Hans Hull Resigns

Pliant Therapeutics Completes $32.4 Million Voluntary Debt Prepayment, Fully Repays Loan Agreement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PLRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PLRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRX\",,,,,undefined,":{"symbol":"PLRX","market":"US","secType":"STK","nameCN":"Pliant Therapeutics, Inc.","latestPrice":1.205,"timestamp":1771428927679,"preClose":1.13,"halted":0,"volume":474467,"delay":0,"changeRate":0.06637168141592936,"floatShares":55573062,"shares":61449385,"eps":-2.866764,"marketStatus":"Trading","change":0.075,"latestTime":"02-18 10:35:34 EST","open":1.13,"high":1.23,"low":1.13,"amount":569365.3819035001,"amplitude":0.088496,"askPrice":1.21,"askSize":1840,"bidPrice":1.2,"bidSize":3240,"shortable":3,"etf":0,"ttmEps":-2.866764,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771448400000},"marketStatusCode":2,"adr":0,"listingDate":1591156800000,"exchange":"NASDAQ","adjPreClose":1.13,"preHourTrading":{"tag":"盘前","latestPrice":1.1277,"preClose":1.13,"latestTime":"08:00 EST","volume":1,"amount":1.1277,"timestamp":1771419603824,"change":-0.0023,"changeRate":-0.002035,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.1688,"preClose":1.13,"latestTime":"19:45 EST","volume":135,"amount":156.2966,"timestamp":1771375508316,"change":0.0388,"changeRate":0.034336,"amplitude":0.034336},"volumeRatio":3.852695,"impliedVol":3.1814,"impliedVolPercentile":0.8327},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRX\",,,,,undefined,":{"symbol":"PLRX","floatShares":55573062,"roa":"-32.87%","roe":"-64.27%","lyrEps":-3.47388,"volumeRatio":3.852695,"shares":61449385,"dividePrice":0,"high":1.23,"amplitude":0.088496,"preClose":1.13,"low":1.13,"week52Low":1.09,"pbRate":"0.37","week52High":3.46,"institutionHeld":0,"latestPrice":1.205,"committee":0.275591,"eps":-2.866764,"divideRate":0,"volume":474467,"delay":0,"ttmEps":-2.866764,"open":1.13,"prevYearClose":1.22,"prevWeekClose":1.11,"prevMonthClose":1.21,"prevQuarterClose":1.22,"fiveDayClose":1.16,"twentyDayClose":1.28,"sixtyDayClose":1.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"PLRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.53,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2025-08-07","symbol":"PLRX","fiscalQuarterEnding":"2025/06","expectedEps":-0.62,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2025-05-08","symbol":"PLRX","fiscalQuarterEnding":"2025/03","expectedEps":-0.73,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.92},{"market":"US","date":"2025-03-03","symbol":"PLRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.99,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"post","actualEps":-0.82},{"market":"US","date":"2024-11-07","symbol":"PLRX","fiscalQuarterEnding":"2024/09","expectedEps":-0.99,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.1429,"hold":0.7143,"sell":0.1429,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.7143,"analysts":7,"updateTime":1760331600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLRX","date":"2026-02-17","current":-0.394173,"percent":0.95306,"low":-34.61699,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"high":72.284133,"avg":-5.373895,"sd":10.677382,"marketCap":68208817},"quantilePoints":[{"date":"2021-02-19","current":59.833796,"twenty":-1327.670062,"median":37.820144,"eighty":49.094026,"marketCap":1176511925},{"date":"2021-02-26","current":59.707488,"twenty":-1324.704985,"median":37.881941,"eighty":49.422427,"marketCap":1174028335},{"date":"2021-03-05","current":56.856541,"twenty":-1310.905976,"median":38.036435,"eighty":49.707521,"marketCap":1117970168},{"date":"2021-03-12","current":68.67534,"twenty":-1298.817587,"median":38.391771,"eighty":49.989007,"marketCap":1350363205},{"date":"2021-03-19","current":-33.71349,"twenty":-1295.05422,"median":38.160031,"eighty":49.989007,"marketCap":1400222362},{"date":"2021-03-26","current":-34.117914,"twenty":-1290.94873,"median":37.943739,"eighty":49.938484,"marketCap":1417019312},{"date":"2021-04-01","current":-30.891125,"twenty":-1286.011071,"median":37.866492,"eighty":49.887961,"marketCap":1283001092},{"date":"2021-04-09","current":-29.170171,"twenty":-1278.752502,"median":37.78152,"eighty":49.826612,"marketCap":1211524708},{"date":"2021-04-16","current":-25.754077,"twenty":-1271.789773,"median":37.6502,"eighty":49.732783,"marketCap":1069644086},{"date":"2021-04-23","current":-25.702449,"twenty":-1263.008586,"median":37.565229,"eighty":49.613692,"marketCap":1067499795},{"date":"2021-04-30","current":-28.94002,"twenty":-1220.261474,"median":37.480257,"eighty":49.527081,"marketCap":1201965863},{"date":"2021-05-07","current":-28.421692,"twenty":-1073.913346,"median":37.148094,"eighty":49.487384,"marketCap":1180438116},{"date":"2021-05-14","current":-13.350123,"twenty":-931.32767,"median":36.676887,"eighty":49.44047,"marketCap":1006839574},{"date":"2021-05-21","current":-14.378154,"twenty":-931.32767,"median":36.3679,"eighty":49.386339,"marketCap":1084371606},{"date":"2021-05-28","current":-14.306763,"twenty":-572.643398,"median":35.641777,"eighty":49.328598,"marketCap":1078987437},{"date":"2021-06-04","current":-14.663718,"twenty":-34.577408,"median":35.240093,"eighty":49.227552,"marketCap":1105908281},{"date":"2021-06-11","current":-15.706027,"twenty":-34.382941,"median":34.92338,"eighty":49.144549,"marketCap":1184517147},{"date":"2021-06-18","current":-13.76895,"twenty":-34.23666,"median":34.79206,"eighty":49.000198,"marketCap":1038426698},{"date":"2021-06-25","current":-13.945048,"twenty":-34.207404,"median":34.166359,"eighty":48.798106,"marketCap":1051707648},{"date":"2021-07-02","current":-13.393007,"twenty":-34.062843,"median":33.803298,"eighty":48.559925,"marketCap":1010073774},{"date":"2021-07-09","current":-12.845284,"twenty":-33.842561,"median":33.401614,"eighty":48.069129,"marketCap":968765636},{"date":"2021-07-16","current":-11.806993,"twenty":-33.71349,"median":33.185322,"eighty":47.816513,"marketCap":890459774},{"date":"2021-07-23","current":-12.102287,"twenty":-33.128365,"median":32.690941,"eighty":47.419546,"marketCap":912730249},{"date":"2021-07-30","current":-9.620865,"twenty":-32.93906,"median":30.883361,"eighty":47.419546,"marketCap":725586424},{"date":"2021-08-06","current":-10.773464,"twenty":-32.93906,"median":-10.278132,"eighty":47.383458,"marketCap":812513114},{"date":"2021-08-13","current":-8.766861,"twenty":-32.431379,"median":-9.565415,"eighty":47.34737,"marketCap":712289911},{"date":"2021-08-20","current":-8.1653,"twenty":-32.362541,"median":-9.25784,"eighty":47.329326,"marketCap":663414317},{"date":"2021-08-27","current":-7.948562,"twenty":-31.829045,"median":-8.494832,"eighty":47.184975,"marketCap":645804727},{"date":"2021-09-03","current":-8.545699,"twenty":-31.45904,"median":-8.426271,"eighty":47.148887,"marketCap":694320942},{"date":"2021-09-10","current":-8.205109,"twenty":-31.417737,"median":-8.426271,"eighty":47.076711,"marketCap":666648731},{"date":"2021-09-17","current":-8.067989,"twenty":-31.269735,"median":-8.34223,"eighty":46.769963,"marketCap":655507970},{"date":"2021-09-24","current":-7.820288,"twenty":-30.959963,"median":-8.31569,"eighty":46.452389,"marketCap":635382726},{"date":"2021-10-01","current":-7.638935,"twenty":-30.332343,"median":-8.185205,"eighty":46.289994,"marketCap":620648171},{"date":"2021-10-08","current":-7.815864,"twenty":-29.736518,"median":-8.098952,"eighty":46.048205,"marketCap":635023346},{"date":"2021-10-15","current":-7.957408,"twenty":-29.260634,"median":-8.072412,"eighty":45.936332,"marketCap":646523486},{"date":"2021-10-22","current":-7.599126,"twenty":-28.98605,"median":-8.067989,"eighty":45.907462,"marketCap":617413757},{"date":"2021-10-29","current":-7.046221,"twenty":-28.931394,"median":-8.030392,"eighty":45.860547,"marketCap":572491336},{"date":"2021-11-05","current":-7.807018,"twenty":-28.743375,"median":-7.957408,"eighty":45.705369,"marketCap":634304588},{"date":"2021-11-12","current":-6.586536,"twenty":-28.476735,"median":-7.935292,"eighty":45.568235,"marketCap":604373929},{"date":"2021-11-19","current":-5.891356,"twenty":-28.421583,"median":-7.895483,"eighty":45.427492,"marketCap":540584910},{"date":"2021-11-26","current":-5.69105,"twenty":-28.328624,"median":-7.855674,"eighty":45.312011,"marketCap":522205023},{"date":"2021-12-03","current":-4.819129,"twenty":-28.219734,"median":-7.837981,"eighty":45.102701,"marketCap":442198456},{"date":"2021-12-10","current":-5.934559,"twenty":-27.716765,"median":-7.815864,"eighty":44.80678,"marketCap":544549199},{"date":"2021-12-17","current":-6.072024,"twenty":-26.810911,"median":-7.778267,"eighty":44.601078,"marketCap":557162847},{"date":"2021-12-23","current":-6.032748,"twenty":-26.395993,"median":-7.725188,"eighty":44.492815,"marketCap":553558947},{"date":"2021-12-31","current":-5.30222,"twenty":-26.234224,"median":-7.669897,"eighty":44.341246,"marketCap":486526419},{"date":"2022-01-07","current":-5.168683,"twenty":-26.027709,"median":-7.641146,"eighty":43.979394,"marketCap":474273161},{"date":"2022-01-14","current":-4.980159,"twenty":-25.908963,"median":-7.541623,"eighty":43.218166,"marketCap":456974443},{"date":"2022-01-21","current":-4.214283,"twenty":-25.743751,"median":-7.439889,"eighty":42.642932,"marketCap":386698405},{"date":"2022-01-28","current":-4.520634,"twenty":-25.688681,"median":-7.415561,"eighty":42.514698,"marketCap":414808820},{"date":"2022-02-04","current":-4.143587,"twenty":-25.506259,"median":-7.289499,"eighty":42.448785,"marketCap":380211386},{"date":"2022-02-11","current":-4.500996,"twenty":-24.888437,"median":-7.001988,"eighty":42.358568,"marketCap":413006871},{"date":"2022-02-18","current":-3.872584,"twenty":-24.413454,"median":-6.586536,"eighty":41.87644,"marketCap":355344480},{"date":"2022-02-25","current":-3.790106,"twenty":-24.248242,"median":-6.535477,"eighty":40.995894,"marketCap":347776292},{"date":"2022-03-04","current":-3.226576,"twenty":-15.706027,"median":-6.421578,"eighty":40.863676,"marketCap":313826497},{"date":"2022-03-11","current":-3.126326,"twenty":-15.658433,"median":-6.123082,"eighty":40.50834,"marketCap":304075846},{"date":"2022-03-18","current":-3.026076,"twenty":-15.644155,"median":-6.052386,"eighty":40.50834,"marketCap":294325196},{"date":"2022-03-25","current":-2.795871,"twenty":-15.168215,"median":-6.005255,"eighty":40.153004,"marketCap":271934813},{"date":"2022-04-01","current":-2.599083,"twenty":-15.030192,"median":-5.952233,"eighty":40.153004,"marketCap":252794647},{"date":"2022-04-08","current":-2.6325,"twenty":-15.025433,"median":-5.899211,"eighty":39.226039,"marketCap":256044863},{"date":"2022-04-14","current":-2.788445,"twenty":-14.937859,"median":-5.848152,"eighty":38.966489,"marketCap":271212542},{"date":"2022-04-22","current":-2.677056,"twenty":-14.885506,"median":-5.655701,"eighty":38.864524,"marketCap":260378486},{"date":"2022-04-29","current":-2.179175,"twenty":-14.836009,"median":-5.585005,"eighty":38.68222,"marketCap":211953082},{"date":"2022-05-06","current":-1.863083,"twenty":-14.795077,"median":-5.531983,"eighty":38.490648,"marketCap":181209034},{"date":"2022-05-13","current":-1.736016,"twenty":-14.688467,"median":-5.420047,"eighty":38.42885,"marketCap":177953782},{"date":"2022-05-20","current":-1.75013,"twenty":-14.576145,"median":-5.312039,"eighty":38.397951,"marketCap":179400561},{"date":"2022-05-27","current":-1.979482,"twenty":-14.531406,"median":-5.223669,"eighty":38.280536,"marketCap":202910715},{"date":"2022-06-03","current":-2.282931,"twenty":-14.517128,"median":-5.168683,"eighty":38.141491,"marketCap":234016457},{"date":"2022-06-10","current":-2.44877,"twenty":-14.494283,"median":-5.129407,"eighty":38.030255,"marketCap":251016107},{"date":"2022-06-17","current":-2.501698,"twenty":-14.465727,"median":-5.066566,"eighty":37.968458,"marketCap":256441528},{"date":"2022-06-24","current":-2.886303,"twenty":-14.446689,"median":-4.933029,"eighty":37.91902,"marketCap":295866248},{"date":"2022-07-01","current":-2.70635,"twenty":-14.412422,"median":-4.72094,"eighty":37.875761,"marketCap":277419819},{"date":"2022-07-08","current":-3.133297,"twenty":-14.363876,"median":-4.618823,"eighty":37.863402,"marketCap":321184875},{"date":"2022-07-15","current":-9.577476,"twenty":-14.278207,"median":-4.783781,"eighty":37.838683,"marketCap":981758380},{"date":"2022-07-22","current":-8.771451,"twenty":-14.162077,"median":-4.956594,"eighty":37.786155,"marketCap":899135150},{"date":"2022-07-29","current":-8.235681,"twenty":-14.145895,"median":-5.090131,"eighty":37.758346,"marketCap":844215003},{"date":"2022-08-05","current":-8.965846,"twenty":-14.098301,"median":-5.147081,"eighty":37.687278,"marketCap":919061929},{"date":"2022-08-12","current":-9.493745,"twenty":-14.04214,"median":-5.184393,"eighty":37.64402,"marketCap":1036925790},{"date":"2022-08-19","current":-8.562199,"twenty":-14.013583,"median":-5.298293,"eighty":37.610031,"marketCap":935180490},{"date":"2022-08-26","current":-8.473056,"twenty":-13.940289,"median":-5.396482,"eighty":37.569863,"marketCap":925444097},{"date":"2022-09-02","current":-9.181744,"twenty":-13.908877,"median":-5.47307,"eighty":37.551324,"marketCap":1002848417},{"date":"2022-09-09","current":-9.90826,"twenty":-13.859379,"median":-5.553585,"eighty":37.526605,"marketCap":1082200015},{"date":"2022-09-16","current":-10.006318,"twenty":-13.835582,"median":-5.604643,"eighty":37.480257,"marketCap":1092910046},{"date":"2022-09-23","current":-8.838543,"twenty":-13.830823,"median":-5.755854,"eighty":37.464807,"marketCap":965363306},{"date":"2022-09-30","current":-9.311001,"twenty":-13.792747,"median":-5.891356,"eighty":37.38756,"marketCap":1016966186},{"date":"2022-10-07","current":-9.774546,"twenty":-13.76895,"median":-5.94045,"eighty":36.908629,"marketCap":1067595426},{"date":"2022-10-14","current":-10.064261,"twenty":-13.588093,"median":-5.969907,"eighty":36.723236,"marketCap":1099238701},{"date":"2022-10-21","current":-10.728377,"twenty":-13.569055,"median":-6.026857,"eighty":36.676887,"marketCap":1171774825},{"date":"2022-10-28","current":-11.151807,"twenty":-13.53574,"median":-6.099517,"eighty":36.429697,"marketCap":1218022689},{"date":"2022-11-04","current":-9.992946,"twenty":-13.421514,"median":-6.284113,"eighty":36.398798,"marketCap":1091449588},{"date":"2022-11-11","current":-8.732359,"twenty":-13.407236,"median":-6.464781,"eighty":36.337001,"marketCap":984940263},{"date":"2022-11-18","current":-8.684807,"twenty":-13.393007,"median":-6.572789,"eighty":35.981664,"marketCap":979576727},{"date":"2022-11-25","current":-8.516212,"twenty":-13.377737,"median":-6.842842,"eighty":35.709754,"marketCap":960560554},{"date":"2022-12-02","current":-7.70782,"twenty":-13.354882,"median":-7.285076,"eighty":35.382227,"marketCap":869380440},{"date":"2022-12-09","current":-7.880738,"twenty":-13.23202,"median":-7.354643,"eighty":35.255542,"marketCap":888884208},{"date":"2022-12-16","current":-8.079594,"twenty":-12.916726,"median":-7.426828,"eighty":35.128857,"marketCap":911313541},{"date":"2022-12-23","current":-7.872092,"twenty":-12.711926,"median":-7.437677,"eighty":35.014531,"marketCap":887909019},{"date":"2022-12-30","current":-8.356263,"twenty":-12.630005,"median":-7.504026,"eighty":34.909476,"marketCap":942519569},{"date":"2023-01-06","current":-8.295741,"twenty":-12.595713,"median":-7.619031,"eighty":34.841498,"marketCap":935693250},{"date":"2023-01-13","current":-10.132995,"twenty":-12.537607,"median":-7.665474,"eighty":34.810599,"marketCap":1142920781},{"date":"2023-01-20","current":-9.730961,"twenty":-12.444256,"median":-7.683167,"eighty":34.761161,"marketCap":1097574521},{"date":"2023-01-27","current":-17.650403,"twenty":-12.811944,"median":-7.708763,"eighty":34.557229,"marketCap":1990824297},{"date":"2023-02-03","current":-17.268714,"twenty":-13.369161,"median":-7.749516,"eighty":34.208073,"marketCap":1947772808},{"date":"2023-02-10","current":-16.412649,"twenty":-13.512895,"median":-7.80923,"eighty":34.050489,"marketCap":1851215552},{"date":"2023-02-17","current":-16.257472,"twenty":-13.787988,"median":-7.820288,"eighty":33.852736,"marketCap":1833712726},{"date":"2023-02-24","current":-16.066085,"twenty":-13.859379,"median":-7.829134,"eighty":33.803298,"marketCap":1812125908},{"date":"2023-03-03","current":-16.340233,"twenty":-14.044996,"median":-7.853462,"eighty":33.741501,"marketCap":1843047567},{"date":"2023-03-10","current":-13.372677,"twenty":-14.154462,"median":-7.872092,"eighty":33.401614,"marketCap":1649131882},{"date":"2023-03-17","current":-12.952092,"twenty":-14.111627,"median":-7.895483,"eighty":33.278018,"marketCap":1597264975},{"date":"2023-03-24","current":-12.235187,"twenty":-14.044996,"median":-7.939715,"eighty":33.262569,"marketCap":1508855475},{"date":"2023-03-31","current":-12.713124,"twenty":-14.030717,"median":-7.952985,"eighty":33.108075,"marketCap":1567795142},{"date":"2023-04-06","current":-11.857617,"twenty":-13.979316,"median":-7.970678,"eighty":33.061727,"marketCap":1462293138},{"date":"2023-04-14","current":-12.455038,"twenty":-13.93077,"median":-8.008265,"eighty":32.826896,"marketCap":1535967722},{"date":"2023-04-21","current":-13.941422,"twenty":-13.942872,"median":-8.032603,"eighty":32.357234,"marketCap":1719270086},{"date":"2023-04-28","current":-13.431452,"twenty":-14.036429,"median":-8.067989,"eighty":31.476618,"marketCap":1656380040},{"date":"2023-05-05","current":-10.879476,"twenty":-13.979316,"median":-8.071912,"eighty":30.852462,"marketCap":1341667832},{"date":"2023-05-12","current":-10.096368,"twenty":-13.943598,"median":-8.079594,"eighty":17.857237,"marketCap":1340484703},{"date":"2023-05-19","current":-9.864677,"twenty":-13.941422,"median":-8.089123,"eighty":-1.450208,"marketCap":1309723360},{"date":"2023-05-26","current":-9.352287,"twenty":-13.921251,"median":-8.096886,"eighty":-1.541949,"marketCap":1241693759},{"date":"2023-06-02","current":-9.690912,"twenty":-13.884128,"median":-8.10568,"eighty":-1.561003,"marketCap":1286652657},{"date":"2023-06-09","current":-10.14538,"twenty":-13.857785,"median":-8.119173,"eighty":-1.603345,"marketCap":1346991911},{"date":"2023-06-16","current":-10.421629,"twenty":-13.847469,"median":-8.1653,"eighty":-1.652038,"marketCap":1383669225},{"date":"2023-06-21","current":-9.86468,"twenty":-13.843506,"median":-8.1653,"eighty":-1.654155,"marketCap":1309723670},{"date":"2023-06-30","current":-8.13591,"twenty":-13.83463,"median":-8.1653,"eighty":-1.668269,"marketCap":1080196667},{"date":"2023-07-07","current":-8.180466,"twenty":-13.830823,"median":-8.1653,"eighty":-1.707788,"marketCap":1086112311},{"date":"2023-07-11","current":-8.376512,"twenty":-13.815593,"median":-8.1653,"eighty":-1.719079,"marketCap":1112141147},{"date":"2023-07-21","current":-7.797285,"twenty":-13.787988,"median":-8.157407,"eighty":-1.736016,"marketCap":1035237770},{"date":"2023-07-27","current":-7.64134,"twenty":-13.773709,"median":-8.129366,"eighty":-1.736016,"marketCap":1014533014},{"date":"2023-08-04","current":-8.688404,"twenty":-13.76059,"median":-8.122823,"eighty":-1.737427,"marketCap":1153550658},{"date":"2023-08-11","current":-7.780939,"twenty":-13.710694,"median":-8.119173,"eighty":-1.739544,"marketCap":1123684360},{"date":"2023-08-18","current":-7.080738,"twenty":-13.629807,"median":-8.098952,"eighty":-1.743778,"marketCap":1022564734},{"date":"2023-08-25","current":-6.844575,"twenty":-13.590754,"median":-8.096348,"eighty":-1.771301,"marketCap":988459298},{"date":"2023-09-01","current":-6.99373,"twenty":-13.588093,"median":-8.092563,"eighty":-1.803057,"marketCap":1009999574},{"date":"2023-09-06","current":-6.968871,"twenty":-13.580478,"median":-8.085682,"eighty":-1.824228,"marketCap":1006409528},{"date":"2023-09-15","current":-6.703706,"twenty":-13.569055,"median":-8.078215,"eighty":-1.855984,"marketCap":968115705},{"date":"2023-09-22","current":-6.604269,"twenty":-13.554911,"median":-8.069951,"eighty":-1.861663,"marketCap":953755522},{"date":"2023-09-29","current":-6.794857,"twenty":-13.541994,"median":-8.067989,"eighty":-1.907517,"marketCap":981279207},{"date":"2023-10-04","current":-7.068308,"twenty":-13.53574,"median":-8.052508,"eighty":-1.93714,"marketCap":1020769711},{"date":"2023-10-10","current":-7.076594,"twenty":-13.512573,"median":-8.035229,"eighty":-1.953629,"marketCap":1021966393},{"date":"2023-10-20","current":-5.750769,"twenty":-13.489406,"median":-8.033017,"eighty":-1.970118,"marketCap":830497280},{"date":"2023-10-27","current":-5.651332,"twenty":-13.468549,"median":-8.030392,"eighty":-1.978587,"marketCap":816137096},{"date":"2023-11-02","current":-6.148517,"twenty":-13.440726,"median":-8.02452,"eighty":-1.979258,"marketCap":887938014},{"date":"2023-11-10","current":-5.471444,"twenty":-13.423502,"median":-8.008265,"eighty":-1.985128,"marketCap":849644191},{"date":"2023-11-17","current":-5.207103,"twenty":-13.410092,"median":-7.970678,"eighty":-1.995007,"marketCap":808595433},{"date":"2023-11-24","current":-5.511815,"twenty":-13.398699,"median":-7.948775,"eighty":-2.003717,"marketCap":855913239},{"date":"2023-12-01","current":-5.357531,"twenty":-13.392279,"median":-7.947072,"eighty":-2.050507,"marketCap":831954856},{"date":"2023-12-08","current":-5.669957,"twenty":-13.38107,"median":-7.939715,"eighty":-2.092157,"marketCap":880470582},{"date":"2023-12-15","current":-6.468379,"twenty":-13.373174,"median":-7.924228,"eighty":-2.112805,"marketCap":1004455215},{"date":"2023-12-22","current":-6.36038,"twenty":-13.363655,"median":-7.895483,"eighty":-2.144043,"marketCap":987684347},{"date":"2023-12-29","current":-7.370944,"twenty":-13.350123,"median":-7.880738,"eighty":-2.179175,"marketCap":1144611757},{"date":"2024-01-05","current":-7.205088,"twenty":-13.283362,"median":-7.868306,"eighty":-2.205438,"marketCap":1118856495},{"date":"2024-01-12","current":-6.695949,"twenty":-13.224516,"median":-7.855674,"eighty":-2.258937,"marketCap":1039793830},{"date":"2024-01-19","current":-6.368094,"twenty":-13.209972,"median":-7.846827,"eighty":-2.301279,"marketCap":988882266},{"date":"2024-01-26","current":-6.638092,"twenty":-13.184538,"median":-7.821737,"eighty":-2.34715,"marketCap":1030809437},{"date":"2024-02-02","current":-7.104803,"twenty":-13.155693,"median":-7.811441,"eighty":-2.37681,"marketCap":1103283546},{"date":"2024-02-09","current":-6.283238,"twenty":-13.127653,"median":-7.789112,"eighty":-2.38776,"marketCap":975705155},{"date":"2024-02-16","current":-6.479951,"twenty":-13.044331,"median":-7.749516,"eighty":-2.409252,"marketCap":1006252094},{"date":"2024-02-23","current":-6.163667,"twenty":-12.97121,"median":-7.709707,"eighty":-2.429011,"marketCap":957137408},{"date":"2024-03-01","current":-5.891734,"twenty":-12.93073,"median":-7.684686,"eighty":-2.44877,"marketCap":950548853},{"date":"2024-03-08","current":-5.839619,"twenty":-12.818852,"median":-7.665474,"eighty":-2.455827,"marketCap":942140712},{"date":"2024-03-15","current":-5.56332,"twenty":-12.713124,"median":-7.640137,"eighty":-2.487584,"marketCap":897563722},{"date":"2024-03-22","current":-5.660398,"twenty":-12.707389,"median":-7.599126,"eighty":-2.50261,"marketCap":913225908},{"date":"2024-03-28","current":-5.432638,"twenty":-12.684448,"median":-7.541623,"eighty":-2.506259,"marketCap":876480010},{"date":"2024-04-05","current":-5.432638,"twenty":-12.678586,"median":-7.468313,"eighty":-2.524824,"marketCap":876480010},{"date":"2024-04-12","current":-5.402767,"twenty":-12.66533,"median":-7.439889,"eighty":-2.526397,"marketCap":871660876},{"date":"2024-04-19","current":-4.551467,"twenty":-12.603198,"median":-7.432116,"eighty":-2.547102,"marketCap":734315555},{"date":"2024-04-26","current":-4.441579,"twenty":-12.597618,"median":-7.395657,"eighty":-2.550815,"marketCap":716586536},{"date":"2024-05-03","current":-4.953781,"twenty":-12.592855,"median":-7.354643,"eighty":-2.580518,"marketCap":799223199},{"date":"2024-05-10","current":-4.879261,"twenty":-12.584081,"median":-7.289499,"eighty":-2.591657,"marketCap":833099739},{"date":"2024-05-17","current":-5.515226,"twenty":-12.574522,"median":-7.205088,"eighty":-2.599083,"marketCap":941686237},{"date":"2024-05-24","current":-4.734403,"twenty":-12.478935,"median":-7.143374,"eighty":-2.602796,"marketCap":808366148},{"date":"2024-05-31","current":-4.299827,"twenty":-12.459817,"median":-7.124089,"eighty":-2.608737,"marketCap":734165375},{"date":"2024-06-07","current":-4.077239,"twenty":-12.454795,"median":-7.092771,"eighty":-2.625074,"marketCap":696160101},{"date":"2024-06-14","current":-4.229164,"twenty":-12.452048,"median":-7.072451,"eighty":-2.631015,"marketCap":722100209},{"date":"2024-06-21","current":-3.801655,"twenty":-12.431092,"median":-7.048978,"eighty":-2.641411,"marketCap":649105952},{"date":"2024-06-28","current":-3.766323,"twenty":-12.411926,"median":-7.044655,"eighty":-2.650322,"marketCap":643073369},{"date":"2024-07-05","current":-3.738058,"twenty":-12.376607,"median":-7.016518,"eighty":-2.656082,"marketCap":638247302},{"date":"2024-07-12","current":-4.416421,"twenty":-12.33089,"median":-6.965947,"eighty":-2.664558,"marketCap":754072900},{"date":"2024-07-15","current":-4.504749,"twenty":-12.32137,"median":-6.963266,"eighty":-2.667094,"marketCap":769154358},{"date":"2024-08-02","current":-5.070051,"twenty":-12.31185,"median":-6.960585,"eighty":-2.66963,"marketCap":865675689},{"date":"2024-08-09","current":-4.020525,"twenty":-12.292799,"median":-6.939837,"eighty":-2.673343,"marketCap":745425470},{"date":"2024-08-16","current":-4.076275,"twenty":-12.268642,"median":-6.904233,"eighty":-2.677056,"marketCap":755761712},{"date":"2024-08-23","current":-4.328787,"twenty":-12.235187,"median":-6.877334,"eighty":-2.702822,"marketCap":802578810},{"date":"2024-08-30","current":-4.318949,"twenty":-12.139599,"median":-6.844575,"eighty":-2.70635,"marketCap":800754767},{"date":"2024-09-06","current":-4.377978,"twenty":-12.124305,"median":-6.815573,"eighty":-2.709172,"marketCap":811699023},{"date":"2024-09-13","current":-3.882791,"twenty":-12.105926,"median":-6.793617,"eighty":-2.713324,"marketCap":719888872},{"date":"2024-09-20","current":-4.138583,"twenty":-12.00703,"median":-6.765854,"eighty":-2.740919,"marketCap":767313983},{"date":"2024-09-27","current":-3.663072,"twenty":-11.922253,"median":-6.727367,"eighty":-2.750572,"marketCap":679151917},{"date":"2024-10-04","current":-3.646675,"twenty":-11.867496,"median":-6.703706,"eighty":-2.757685,"marketCap":676111846},{"date":"2024-10-11","current":-3.804086,"twenty":-11.817118,"median":-6.68147,"eighty":-2.761819,"marketCap":705296530},{"date":"2024-10-18","current":-4.810857,"twenty":-11.784131,"median":-6.661235,"eighty":-2.762454,"marketCap":891956904},{"date":"2024-10-25","current":-4.486198,"twenty":-11.770795,"median":-6.635682,"eighty":-2.783247,"marketCap":831763494},{"date":"2024-10-31","current":-4.725593,"twenty":-11.763175,"median":-6.607681,"eighty":-2.790673,"marketCap":876148534},{"date":"2024-11-08","current":-4.579379,"twenty":-11.582568,"median":-6.559043,"eighty":-2.794386,"marketCap":923573645},{"date":"2024-11-15","current":-3.877257,"twenty":-11.410027,"median":-6.515391,"eighty":-2.802554,"marketCap":781969055},{"date":"2024-11-22","current":-3.877257,"twenty":-11.350161,"median":-6.468379,"eighty":-2.80701,"marketCap":781969055},{"date":"2024-11-29","current":-4.163902,"twenty":-11.286413,"median":-6.464522,"eighty":-2.814734,"marketCap":839779997},{"date":"2024-12-06","current":-4.308734,"twenty":-11.199279,"median":-6.435512,"eighty":-2.831962,"marketCap":868989736},{"date":"2024-12-13","current":-4.178989,"twenty":-11.166854,"median":-6.406665,"eighty":-2.843397,"marketCap":842822678},{"date":"2024-12-20","current":-4.013036,"twenty":-11.125064,"median":-6.395231,"eighty":-2.852309,"marketCap":809353185},{"date":"2024-12-27","current":-4.233301,"twenty":-11.073139,"median":-6.364237,"eighty":-2.859735,"marketCap":853776330},{"date":"2025-01-03","current":-4.007002,"twenty":-11.025893,"median":-6.344952,"eighty":-2.862705,"marketCap":808136113},{"date":"2025-01-10","current":-3.804841,"twenty":-10.987561,"median":-6.287095,"eighty":-2.864647,"marketCap":767364186},{"date":"2025-01-17","current":-3.500092,"twenty":-10.938755,"median":-6.218951,"eighty":-2.882069,"marketCap":705902026},{"date":"2025-01-24","current":-3.361295,"twenty":-10.899265,"median":-6.175658,"eighty":-2.911708,"marketCap":677909360},{"date":"2025-01-31","current":-3.216464,"twenty":-10.863697,"median":-6.164976,"eighty":-2.953687,"marketCap":648699621},{"date":"2025-02-07","current":-3.605698,"twenty":-10.845544,"median":-6.148517,"eighty":-2.977064,"marketCap":727200794},{"date":"2025-02-14","current":-0.992698,"twenty":-10.815997,"median":-6.116588,"eighty":-2.864161,"marketCap":200208419},{"date":"2025-02-21","current":-0.908213,"twenty":-10.798986,"median":-6.096878,"eighty":-2.843397,"marketCap":183169405},{"date":"2025-02-28","current":-0.983647,"twenty":-10.788142,"median":-6.072024,"eighty":-2.800327,"marketCap":198382810},{"date":"2025-03-07","current":-0.460064,"twenty":-10.771475,"median":-6.03677,"eighty":-2.762454,"marketCap":96753339},{"date":"2025-03-14","current":-0.442593,"twenty":-10.752446,"median":-6.005255,"eighty":-2.727552,"marketCap":93079162},{"date":"2025-03-21","current":-0.460064,"twenty":-10.717822,"median":-5.978073,"eighty":-2.687362,"marketCap":96753339},{"date":"2025-03-28","current":-0.439682,"twenty":-10.696499,"median":-5.946342,"eighty":-2.655647,"marketCap":92466799},{"date":"2025-04-04","current":-0.381446,"twenty":-10.678526,"median":-5.895473,"eighty":-2.605766,"marketCap":80219541},{"date":"2025-04-11","current":-0.365431,"twenty":-10.66296,"median":-5.889812,"eighty":-2.562696,"marketCap":76851545},{"date":"2025-04-17","current":-0.419299,"twenty":-10.657954,"median":-5.848152,"eighty":-2.525139,"marketCap":88180259},{"date":"2025-04-25","current":-0.457152,"twenty":-10.641908,"median":-5.82245,"eighty":-2.455827,"marketCap":96140976},{"date":"2025-05-02","current":-0.472867,"twenty":-10.632103,"median":-5.801099,"eighty":-2.383889,"marketCap":99445770},{"date":"2025-05-09","current":-0.426164,"twenty":-10.617375,"median":-5.716795,"eighty":-2.292105,"marketCap":89623965},{"date":"2025-05-16","current":-0.383114,"twenty":-10.590279,"median":-5.669957,"eighty":-2.10499,"marketCap":84099200},{"date":"2025-05-23","current":-0.374724,"twenty":-10.535692,"median":-5.654203,"eighty":-1.988656,"marketCap":82257612},{"date":"2025-05-30","current":-0.383114,"twenty":-10.435887,"median":-5.642957,"eighty":-1.922329,"marketCap":84099200},{"date":"2025-06-06","current":-0.450228,"twenty":-10.29849,"median":-5.596672,"eighty":-1.739544,"marketCap":98831907},{"date":"2025-06-13","current":-0.411078,"twenty":-10.250992,"median":-5.56332,"eighty":-1.656272,"marketCap":90237828},{"date":"2025-06-20","current":-0.366335,"twenty":-10.137949,"median":-5.538345,"eighty":-1.285308,"marketCap":80416024},{"date":"2025-06-27","current":-0.363539,"twenty":-10.069609,"median":-5.511815,"eighty":-0.936576,"marketCap":79802161},{"date":"2025-07-03","current":-0.352353,"twenty":-9.998295,"median":-5.476311,"eighty":-0.911834,"marketCap":77346710},{"date":"2025-07-11","current":-0.391503,"twenty":-9.867849,"median":-5.46553,"eighty":-0.66961,"marketCap":85940789},{"date":"2025-07-18","current":-0.397096,"twenty":-9.809312,"median":-5.432638,"eighty":-0.471711,"marketCap":87168514},{"date":"2025-07-25","current":-0.444636,"twenty":-9.706932,"median":-5.411407,"eighty":-0.461811,"marketCap":97604182},{"date":"2025-08-01","current":-0.408282,"twenty":-9.640268,"median":-5.359614,"eighty":-0.455771,"marketCap":89623965},{"date":"2025-08-08","current":-0.469804,"twenty":-9.565337,"median":-5.312039,"eighty":-0.453949,"marketCap":103128947},{"date":"2025-08-15","current":-0.467172,"twenty":-9.528877,"median":-5.298293,"eighty":-0.460064,"marketCap":96686342},{"date":"2025-08-22","current":-0.430095,"twenty":-9.528877,"median":-5.298293,"eighty":-0.460064,"marketCap":89012823},{"date":"2025-08-29","current":-0.48052,"twenty":-9.528877,"median":-5.298293,"eighty":-0.46411,"marketCap":99448809},{"date":"2025-09-05","current":-0.483486,"twenty":-9.538332,"median":-5.30222,"eighty":-0.470567,"marketCap":100062691},{"date":"2025-09-12","current":-0.489418,"twenty":-9.528877,"median":-5.298293,"eighty":-0.473899,"marketCap":101290454},{"date":"2025-09-19","current":-0.441959,"twenty":-9.528877,"median":-5.298293,"eighty":-0.473899,"marketCap":91468349},{"date":"2025-09-26","current":-0.427128,"twenty":-9.528877,"median":-5.298293,"eighty":-0.473899,"marketCap":88398941},{"date":"2025-10-03","current":-0.444926,"twenty":-9.528877,"median":-5.298293,"eighty":-0.473899,"marketCap":92082231},{"date":"2025-10-10","current":-0.45679,"twenty":-9.528877,"median":-5.298293,"eighty":-0.473899,"marketCap":94537757},{"date":"2025-10-17","current":-0.489418,"twenty":-9.528877,"median":-5.298293,"eighty":-0.475073,"marketCap":101290454},{"date":"2025-10-24","current":-0.51908,"twenty":-9.528877,"median":-5.298293,"eighty":-0.483666,"marketCap":107429269},{"date":"2025-10-31","current":-0.486452,"twenty":-9.528877,"median":-5.298293,"eighty":-0.489418,"marketCap":100676572},{"date":"2025-11-07","current":-0.453824,"twenty":-9.528877,"median":-5.298293,"eighty":-0.492268,"marketCap":93923875},{"date":"2025-11-14","current":-0.602242,"twenty":-9.528877,"median":-5.298293,"eighty":-0.497723,"marketCap":105692942},{"date":"2025-11-21","current":-0.54622,"twenty":-9.528877,"median":-5.298293,"eighty":-0.506029,"marketCap":95861040},{"date":"2025-11-28","current":-0.563727,"twenty":-9.528877,"median":-5.298293,"eighty":-0.51908,"marketCap":98933509},{"date":"2025-12-05","current":-0.458685,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":80498694},{"date":"2025-12-12","current":-0.462186,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":81113188},{"date":"2025-12-19","current":-0.423671,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":74353755},{"date":"2025-12-26","current":-0.430673,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":75582743},{"date":"2026-01-02","current":-0.427172,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":74968249},{"date":"2026-01-09","current":-0.458685,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":80498694},{"date":"2026-01-16","current":-0.44818,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":78655212},{"date":"2026-01-23","current":-0.455183,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":79884200},{"date":"2026-01-30","current":-0.434175,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":76197237},{"date":"2026-02-06","current":-0.381654,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":66979829},{"date":"2026-02-13","current":-0.395659,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":69437805},{"date":"2026-02-17","current":-0.388656,"twenty":-9.528877,"median":-5.298293,"eighty":-0.531538,"marketCap":68208817}],"updateTime":1771418382203},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612446974","title":"Tarsus Pharmaceuticals Names Former Allergan CEO David Pyott to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2612446974","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612446974?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:30","pubTimestamp":1771421430,"startTime":"0","endTime":"0","summary":"Tarsus Pharmaceuticals appointed David E. I. Pyott, former Chairman and CEO of Allergan, to its Board of Directors. Pyott has also held senior leadership roles at Novartis and currently serves on the boards of Alnylam Pharmaceuticals and Pliant Therapeutics.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tarsus Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on February 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL4J0bLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","LU1934455863.HKD","IE00B64PRP62.GBP","TARS","IE00B4R5TH58.HKD","LU2023251221.USD","IE00BJJMRZ35.SGD","SG9999014021.USD","LU1496350502.SGD","LU0029864427.USD","LU0511384066.AUD","LU1934455277.USD","LU2237443549.SGD","SG9999014013.SGD","LU0882574055.USD","LU1989772923.USD","IE00BFTCPJ56.SGD","LU0114720955.EUR","ALNY","IE00B19Z3581.USD","BK4585","LU0965509101.SGD","BK4581","LU2468319806.SGD","LU1989771016.USD","SG9999014005.SGD","LU0170899867.USD","PLRX","LU1989772840.SGD","LU1291159041.SGD","LU2095319765.USD","LU2237443382.USD","BK4139","LU0256863902.USD","ABBV","LU1003077747.HKD","SG9999011175.SGD","LU0795875086.SGD","LU1093756168.USD","BK4550","LU1023059063.AUD","IE00BJT1NW94.SGD","LU0109394709.USD","LU0861579265.USD","LU1496350171.SGD","IE00B3PB1722.GBP","NDAQ","IE0002141913.USD","LU1267930490.SGD","LU0128525929.USD"],"gpt_icon":0},{"id":"2606735647","title":"Pliant Therapeutics Unveils Data on Oral Integrin Inhibitor for ICI-Resistant Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2606735647","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606735647?lang=en_us&edition=fundamental","pubTime":"2026-01-27 23:38","pubTimestamp":1769528298,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics Inc. has released a corporate presentation detailing progress in its integrin-based therapeutics pipeline. The lead program, PLN-101095, is an oral small molecule inhibitor targeting αvβ8 and αvβ1 integrins for the treatment of immune checkpoint inhibitor -resistant solid tumors. In the Phase 1 study, four clinical responders—including one complete response and three partial responses—were observed among heavily pre-treated patients at the highest dose levels, with a median treatment duration of 15 months for responders. The compound demonstrated dose-dependent plasma exposure and was well tolerated. Pliant is advancing a Phase 1b dose expansion to further assess efficacy in non-small cell lung cancer and other tumor types. Additionally, the company is developing a cell-specific drug delivery platform for siRNA payloads, with broad applicability across multiple disease areas. Pliant reports a strong cash position to fund operations through 2028. You can access the f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL8jpVpF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2593453239","title":"Pliant Therapeutics Files Initial Beneficial Ownership Statement for Chief Operating Officer Minnie Kuo","url":"https://stock-news.laohu8.com/highlight/detail?id=2593453239","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593453239?lang=en_us&edition=fundamental","pubTime":"2025-12-23 06:03","pubTimestamp":1766441001,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Minnie Kuo, Chief Operating Officer of the company, as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pliant Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDLcntf5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Pliant Therapeutics Files Initial Beneficial Ownership Statement for Chief Operating Officer Minnie Kuo","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2592995830","title":"Pliant Therapeutics Appoints Minnie Kuo as Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2592995830","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592995830?lang=en_us&edition=fundamental","pubTime":"2025-12-17 06:06","pubTimestamp":1765922771,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics Inc. has appointed Minnie Kuo as Chief Operating Officer, effective immediately. Kuo joined the company in September 2023 as Chief Development Officer and has over 20 years of experience in biotechnology and pharmaceuticals, with prior leadership roles at Vir Biotechnology, Nektar Therapeutics, and Gilead Sciences.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pliant Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL3FFM7N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1430594728.SGD","LU1778281490.HKD","BK4568","IE00B19Z3581.USD","LU1674673428.USD","BK4139","LU0289739699.SGD","LU2324357040.USD","LU0889565916.HKD","LU0823416689.USD","BK4535","LU1674673691.USD","LU1585245621.USD","BK4007","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU1839511570.USD","BK4585","BK4578","BK4550","LU0109394709.USD","LU0234570918.USD","IE00BKVL7J92.USD","SG9999015986.USD","GILD","LU0320765992.SGD","NKTR","LU1066051498.USD","LU2089984988.USD","SG9999015945.SGD","LU1066053197.SGD","VIR","PLRX","BK4532","LU0114720955.EUR","LU2087621335.USD","BK4566","LU0882574055.USD","BK4583","IE00BZ1G4Q59.USD","LU1571399168.USD","LU0058720904.USD","LU2468319806.SGD","SG9999015978.USD","IE00B3T34201.USD","IE00B19Z3B42.SGD","IE0002270589.USD","SG9999015952.SGD"],"gpt_icon":0},{"id":"2590661073","title":"Pliant Therapeutics Inc - Terminates Cmo ÉRic Lefebvre Effective December 15 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2590661073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590661073?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:42","pubTimestamp":1765230176,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XE1BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PLRX"],"gpt_icon":0},{"id":"2590836643","title":"Pliant Therapeutics Announces Departure of Chief Medical Officer Éric Lefebvre","url":"https://stock-news.laohu8.com/highlight/detail?id=2590836643","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590836643?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:42","pubTimestamp":1765230148,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics Inc. has announced that Chief Medical Officer ric Lefebvre, M.D., will be leaving the company effective December 15, 2025. Dr. Lefebvre is expected to continue assisting the company as a consultant to support the transition of his responsibilities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pliant Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL7sNhWD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2589983435","title":"Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2589983435","media":"Benzinga_recent_news","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589983435?lang=en_us&edition=fundamental","pubTime":"2025-12-05 02:53","pubTimestamp":1764874380,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics posts interim Phase 1 data showing antitumor activity and durable responses for PLN-101095 in ICI-refractory advanced cancer patients.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/04/Tumor-Microenvironment-Concept-With-Canc.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/04/Tumor-Microenvironment-Concept-With-Canc.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49217318/pliant-cancer-drug-boosts-responses-when-paired-with-mercks-blockbuster-keytruda-in-tough-to-treat-tumors","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49217318/pliant-cancer-drug-boosts-responses-when-paired-with-mercks-blockbuster-keytruda-in-tough-to-treat-tumors","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU1066051811.HKD","LU2324357040.USD","BK4533","LU1974910355.USD","LU2361044865.SGD","SG9999001176.USD","SG9999014567.USD","MRK","IE00BSNM7G36.USD","LU1066051498.USD","LU0266013472.USD","LU1989772923.USD","LU1162221912.USD","CR","BK4550","LU0265550946.USD","SG9999002232.USD","LU1934455277.USD","LU1291159041.SGD","LU1037948897.HKD","SG9999015358.SGD","SG9999001176.SGD","IE00BFTCPJ56.SGD","IE00BN8TJ469.HKD","IE00B1BXHZ80.USD","LU0965509101.SGD","LU2023250504.SGD","LU0203345920.USD","PLRX","LU1116320901.HKD","LU0234572021.USD","LU1989772840.SGD","IE000M9KFDE8.USD","BK4213","LU0320765646.SGD","LU1093756325.SGD","LU0058720904.USD","LU1066053197.SGD","LU0861579265.USD","LU0070302665.USD","LU1983299246.USD","LU1093756168.USD","LU2461242641.AUD","PR","LU1066051225.USD","SG9999013999.USD","LU1035773651.USD","LU0238689110.USD","LU0211331839.USD"],"gpt_icon":0},{"id":"2588488146","title":"BRIEF-Pliant Therapeutics Announces Interim Data From PLN-101095","url":"https://stock-news.laohu8.com/highlight/detail?id=2588488146","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588488146?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:39","pubTimestamp":1764851965,"startTime":"0","endTime":"0","summary":"BRIEF-Pliant Therapeutics Announces Interim Data From PLN-101095Dec 4 (Reuters) - Pliant Therapeutics Inc PLRX.O:PLIANT THERAPEUTICS ANNOUNCES INTERIM DATA FROM PLN-101095 IN PATIENTS WITH IMMUNE CHEC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA02B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2588881986","title":"Pliant Therapeutics Announces Interim Data From Pln-101095 in Patients With Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2588881986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588881986?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:30","pubTimestamp":1764851420,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA02B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2588819998","title":"Pliant Therapeutics Inc: to Accelerate Development of Pln-101095 With Initiation of a Phase 1B Expansion Trial in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2588819998","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588819998?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:30","pubTimestamp":1764851420,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA02B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PLRX"],"gpt_icon":0},{"id":"2588881609","title":"Pliant Therapeutics Reports Promising Interim Results for PLN-101095 in Refractory Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2588881609","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588881609?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:30","pubTimestamp":1764851420,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics Inc. has announced interim data from its Phase 1 dose escalation clinical trial evaluating PLN-101095, an oral, small molecule dual selective inhibitor of αvβ8 and αvβ1, in combination with pembrolizumab for patients with immune checkpoint inhibitor-refractory advanced or metastatic solid tumors. The interim results include one complete response and three partial responses among heavily pretreated patients in high dose cohorts, with a median treatment duration of 15 months. The company plans to initiate a Phase 1b expansion trial in 2026. Final data from this trial will be presented at an upcoming scientific conference.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pliant Therapeutics Inc. published the original co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDLbkKTnY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BKPKM429.USD","PLRX","BK4585","LU2210149790.SGD","LU2095319765.USD","LU2210150020.SGD","BK4588","BK4007","BK4112","LU0314104364.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ"],"gpt_icon":0},{"id":"2584926017","title":"Pliant Therapeutics Q3 Net Income USD -26.301 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584926017","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584926017?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:58","pubTimestamp":1763571483,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - Pliant Therapeutics Q3 operating expenses USD -28.269 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202521:05:47.75 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSDbPhXkD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2582875146","title":"Canaccord Genuity Keeps Their Hold Rating on Pliant Therapeutics (PLRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582875146","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582875146?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:18","pubTimestamp":1762777103,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Edward Nash maintained a Hold rating on Pliant Therapeutics today and set a price target of $4.00. According to TipRanks,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-hold-rating-on-pliant-therapeutics-plrx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-hold-rating-on-pliant-therapeutics-plrx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRX"],"gpt_icon":0},{"id":"2581000233","title":"RBC Capital Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581000233","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581000233?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:38","pubTimestamp":1762519087,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Brian Abrahams from RBC Capital maintained a Hold rating on Pliant Therapeutics, with a price target of $2.00. The ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-hold-rating-for-pliant-therapeutics-plrx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":"46fe14036bd3cdaf869148f08f7adcff","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-hold-rating-for-pliant-therapeutics-plrx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRX"],"gpt_icon":0},{"id":"2581454440","title":"Pliant Therapeutics Q3 net loss narrows to $26.3 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2581454440","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581454440?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:52","pubTimestamp":1762465936,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics Q3 net loss narrows to $26.3 mlnOverviewPliant Q3 net loss narrows to $26.3 mln, driven by BEACON-IPF discontinuationCompany completed voluntary prepayment of Oxford Finance loanOu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL1N3WI1JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PLRX"],"gpt_icon":0},{"id":"2581010986","title":"Pliant Therapeutics reports third quarter net loss of $26.3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581010986","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581010986?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:13","pubTimestamp":1762463605,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics Inc. reported a net loss of $26.3 million for the third quarter of 2025, compared to a net loss of $57.8 million in the same period last year. Research and development expenses were $17.9 million, down from $47.8 million, primarily due to the discontinuation of the BEACON-IPF program. General and administrative expenses decreased to $10.3 million from $14.3 million, mainly due to lower personnel-related costs following a strategic workforce restructuring. As of September 30, 2025, the company had $243.3 million in cash, cash equivalents, and short-term investments. Key business developments include the completion of enrollment in the Phase 1 trial of PLN-101095 in solid tumors and the winding down of BEACON-IPF activities, with close out expected in the fourth quarter of 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated conten","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL10Q7m0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210149790.SGD","BK4585","LU2210150020.SGD","IE00BKPKM429.USD","PLRX","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","BK4112","LU2095319765.USD","IE00BGHQF748.EUR","BK4007"],"gpt_icon":0},{"id":"2580294246","title":"Pliant Therapeutics Inc  expected to post a loss of 52 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580294246","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580294246?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:33","pubTimestamp":1762169625,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics Inc  expected to post a loss of52cents a share - Earnings Preview Pliant Therapeutics Inc PLRX.OQ PLRX.O is expected to  show no change in quarterly revenue when it reports  result","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF0R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2578528285","title":"Pliant Therapeutics Announces CBO Hans Hull’s Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2578528285","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578528285?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:59","pubTimestamp":1761339599,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics ( ($PLRX) ) just unveiled an announcement. On October 20, 2025, Pliant Therapeutics, Inc. announced the resignation of Hans Hul...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pliant-therapeutics-announces-cbo-hans-hulls-resignation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pliant-therapeutics-announces-cbo-hans-hulls-resignation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRX","LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2578754017","title":"Pliant Therapeutics Chief Business Officer Hans Hull Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2578754017","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578754017?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:33","pubTimestamp":1761337989,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics Inc. announced that Hans Hull has resigned as Chief Business Officer, effective October 20, 2025. The company stated that his resignation was not due to any disagreement related to company operations, policies, or practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pliant Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 24, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nNDLY1kV1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRX","BK4007"],"gpt_icon":0},{"id":"2577804894","title":"Pliant Therapeutics Completes $32.4 Million Voluntary Debt Prepayment, Fully Repays Loan Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2577804894","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577804894?lang=en_us&edition=fundamental","pubTime":"2025-10-21 06:44","pubTimestamp":1761000261,"startTime":"0","endTime":"0","summary":"Pliant Therapeutics Inc. has announced the voluntary prepayment of $32.4 million, covering all outstanding principal, accrued interest, fees, and expenses under its Amended and Restated Loan and Security Agreement with Oxford Finance LLC and associated lenders. With this payment, all obligations and liabilities under the agreement have been fully satisfied and discharged, resulting in the termination of the loan agreement and related documents.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pliant Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 20, 2025, and is s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nNDL6zhcG7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PLRX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}